Syndax Pharmaceuticals SNDX Balance Sheet (2015-2026)

NASDAQ SNDX
$20.53 -0.15 (-0.73%)
As of: Sep 4, 2026 · 3:15 PM EDT
Reported Financials

Syndax Pharmaceuticals Quarterly Balance Sheet

Periods 46 quarters
Latest Jun 2026

Syndax Pharmaceuticals reported total assets of $703.65M and total liabilities of $688.55M for the quarter ended Jun 2026, up 18.0% year over year. This balance sheet covers 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
71.55M222.08M188.89M120.35M71.49M74.36M57.52M97.28M94.55M295.39M114.61M105.40M133.02M154.08M153.99M108.64M116.81M134.93M130.89M336.48M
Short-term InvestmentsInvestments (Current)
158.28M0.12M209.16M246.55M266.46M401.45M374.88M301.53M269.01M275.30M319.96M319.70M256.59M418.80M358.20M346.60M319.17M259.14M221.17M211.38M
Cash & Current Investments
229.83M222.19M398.05M366.91M337.95M475.80M432.39M398.80M363.56M570.70M434.58M425.10M389.61M572.88M512.20M455.23M435.98M394.07M352.06M547.86M
Receivables - NetNet Receivables
7.60M15.72M19.45M25.40M38.00M38.12M45.07M
Receivables - OtherOther Receivables
0.18M0.43M0.16M13.10M4.54M3.47M1.39M0.53M3.41M1.23M4.00M3.50M3.50M3.63M10.30M16.60M20.90M28.10M24.70M26.40M
Receivables
1.23M11.24M26.02M36.05M46.30M66.10M62.82M71.47M
Raw Materials
1.74M14.18M21.40M29.03M30.70M29.20M
Work In Process
0.33M0.57M1.27M1.38M2.11M2.87M2.43M
Finished Goods
0.04M2.35M2.25M2.22M1.61M1.38M1.53M
Inventory
0.37M4.66M17.70M25.00M32.75M34.95M33.16M
Prepaid Assets
8.42M1.45M9.03M2.39M2.27M1.92M1.91M3.06M3.75M3.29M6.07M9.58M4.91M8.54M8.46M9.88M9.52M13.50M16.10M17.48M
Current Assets
238.25M448.40M420.06M392.29M357.63M489.79M441.51M409.08M380.97M580.88M453.90M446.06M414.81M603.06M548.75M531.68M529.83M528.08M471.18M675.04M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.16M0.28M0.27M0.26M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.00M0.13M0.18M0.18M0.21M
Long-Term Investments
12.12M5.47M16.56M19.48M15.71M29.83M87.42M29.52M10.03M119.52M89.94M62.63M20.15M27.22M
Long-Term Deferred Tax
48.90M79.60M
Other Non-Current Assets
0.12M0.12M1.03M0.99M0.88M0.81M0.69M0.58M0.59M0.46M0.25M0.22M0.22M0.22M0.22M0.22M0.22M0.10M0.10M0.10M
Non-Current Assets
1.25M1.26M2.17M14.15M2.06M7.45M18.32M22.26M18.25M32.00M89.13M30.89M11.00M121.76M91.96M64.47M21.96M1.62M1.49M28.61M
Assets
239.50M449.66M422.22M406.44M359.69M497.24M459.83M431.34M399.22M612.88M543.03M476.95M425.81M724.82M640.71M596.15M551.79M529.71M472.67M703.65M
Liabilities
Current Liabilities
Accounts Payables
5.12M5.67M8.23M6.44M7.12M4.35M8.06M10.98M6.05M9.96M8.81M11.57M4.90M11.63M10.05M17.35M13.83M16.58M10.84M4.87M
Notes Payables
0.19M
Payables
5.12M5.86M8.23M6.44M7.12M4.35M8.06M10.98M6.05M9.96M8.81M11.57M4.90M11.63M10.05M17.35M13.83M16.58M10.84M4.87M
Accumulated Expenses
13.73M14.46M18.42M16.97M13.21M24.28M15.21M17.73M32.12M39.86M33.40M26.81M48.12M60.10M55.98M71.07M77.11M103.06M74.84M94.30M
Other Accumulated Expenses
0.19M1.70M1.89M3.17M3.19M0.60M0.70M0.53M0.77M0.89M1.08M0.22M0.21M0.42M0.58M0.62M0.59M0.72M1.27M1.55M
Short term Debt
9.49M3.57M7.21M12.12M
Current Leases
0.37M0.36M0.33M0.30M0.47M0.43M0.45M0.96M0.99M1.03M1.04M0.98M0.84M0.47M0.38M0.34M0.33M0.47M0.49M0.51M
Current Deferred Revenue
12.40M
Total Current Liabilities
28.71M20.68M30.55M30.93M20.80M29.07M23.72M30.17M39.17M58.10M50.80M42.47M59.38M103.55M94.55M112.99M114.19M120.12M86.17M99.68M
Non-Current Liabilities
Non-Current Debt
10.99M19.89M16.48M12.99M331.56M329.64M324.41M320.99M343.91M343.96M344.03M
Convertible Debt
244.09M
Non-Current Deffered Revenue
Preferred Stock Liabilities
Operating Leases
0.80M0.71M0.64M0.57M0.77M0.71M0.59M1.11M0.85M0.58M0.33M0.13M0.00M1.58M1.45M1.32M1.19M1.05M0.91M0.76M
Other Non-Current Liabilities
Total Non-Current Liabilities
11.79M20.61M17.12M13.57M0.78M0.72M0.60M1.13M0.86M0.59M0.33M0.14M0.00M333.14M331.10M325.74M322.18M344.96M344.87M588.88M
Total Liabilities
40.50M41.29M47.67M44.50M21.59M29.79M24.32M31.30M40.04M58.68M51.14M42.61M59.38M436.69M425.65M438.73M436.36M465.08M431.05M688.55M
Shareholder's Equity
Total Debt
20.48M20.08M20.05M20.21M343.68M329.64M324.41M320.99M343.91M343.96M344.03M
Common Equity
199.00M408.37M374.55M361.94M338.10M467.45M435.50M400.04M359.19M554.20M491.89M434.34M366.43M288.12M215.06M157.42M115.43M64.63M41.62M15.10M
Liabilities and Shareholders Equity
239.50M449.66M422.22M406.44M359.69M497.24M459.83M431.34M399.22M612.88M543.03M476.95M425.81M724.82M640.71M596.15M551.79M529.71M472.67M703.65M
Retained Earnings
-639.90M-543.70M-580.87M-618.44M-653.85M-693.04M-734.17M-778.78M-829.93M-902.40M-974.80M-1042.86M-1126.99M-1221.16M-1306.00M-1377.85M-1438.57M-1506.58M-1549.25M-1598.62M
Preferred Shares
Treasury Shares